Phathom Pharmaceuticals, Inc.
NASDAQ:PHAT
12.44 (USD) • At close August 27, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 39.503 | 28.519 | 29.664 | 16.352 | 7.324 | 1.912 | 0.682 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 5.038 | 3.724 | 3.815 | 2.356 | 1.376 | 0.426 | -0.223 | 0.121 | 0.123 | 0 | 0.168 | 0.175 | 0.149 | 0.128 | 0.135 | 0.13 | 0.131 | 0.125 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 34.465 | 24.795 | 25.849 | 13.996 | 5.948 | 1.486 | 0.905 | -0.121 | -0.123 | 0 | -0.168 | -0.175 | -0.149 | -0.128 | -0.135 | -0.13 | -0.131 | -0.125 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.872 | 0.869 | 0.871 | 0.856 | 0.812 | 0.777 | 1.327 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 9.076 | 9.184 | 8.583 | 8.693 | 7.376 | 9.43 | 13.394 | 12.263 | 12.764 | 11.479 | 15.946 | 19.02 | 18.815 | 17.66 | 13.553 | 16.608 | 21.597 | 20.58 | 41.654 | 25.77 | 14.859 | 15.865 | 12.704 | 4.469 | 81.669 | 0.429 | 0.014 | 0.006 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 75.872 | 0 | 60.931 | 23.396 | 18.937 | 18.598 | 30.695 | 23.509 | 26.548 | 20.246 | 19.487 | 16.529 | 13.722 | 13.004 | 10.785 | 7.06 | 5.162 | 4.51 | 2.989 | 1.813 | 1.345 | 0.797 | 0.437 | 0.262 | 0.253 | 0.253 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | -3.934 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 85.313 | 94.474 | 76.683 | 76.099 | 75.872 | 62.01 | 56.996 | 23.396 | 18.937 | 18.598 | 30.695 | 23.509 | 26.548 | 20.246 | 19.487 | 16.529 | 13.722 | 13.004 | 10.785 | 7.06 | 5.162 | 4.51 | 2.989 | 1.813 | 1.345 | 0.797 | 0.437 | 0.262 | 0.253 | 0.253 |
| Other Expenses
| 0 | 0 | 0 | 0 | -0.006 | -0.043 | -0.014 | -0.197 | 0.003 | 0 | -0.089 | -0.011 | -0.002 | -0.007 | -0.017 | 0 | 0.01 | -0.001 | -0.002 | -0.004 | 0 | -0.001 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 94.389 | 103.658 | 85.266 | 84.792 | 83.248 | 71.44 | 70.39 | 35.659 | 31.701 | 30.077 | 46.641 | 42.529 | 45.363 | 37.906 | 33.04 | 33.137 | 35.319 | 33.584 | 52.439 | 32.83 | 20.021 | 20.375 | 15.693 | 6.282 | 83.014 | 1.226 | 0.451 | 0.268 | 0.255 | 0.255 |
| Operating Income
| -59.924 | -78.863 | -59.417 | -70.796 | -77.3 | -69.954 | -69.875 | -35.659 | -31.701 | -30.077 | -46.641 | -42.529 | -45.363 | -37.906 | -33.04 | -33.137 | -35.319 | -33.584 | -52.439 | -32.83 | -20.021 | -20.375 | -15.693 | -6.282 | -83.014 | -1.226 | -0.451 | -0.268 | -0.253 | -0.253 |
| Operating Income Ratio
| -1.517 | -2.765 | -2.003 | -4.33 | -10.554 | -36.587 | -102.456 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -15.886 | -15.453 | -15.034 | -14.781 | -14.146 | -12.898 | -9.695 | -7.584 | -9.264 | -7.737 | -8.405 | -8.562 | -5.557 | -2.759 | -2.786 | -3.525 | -1.233 | -1.259 | -1.282 | -1.275 | -1.08 | 0.234 | -82.313 | -61.83 | -4.748 | -0.025 | -0.033 | -0.022 | -0.004 | -0.004 |
| Income Before Tax
| -75.81 | -94.316 | -74.451 | -85.577 | -91.446 | -82.852 | -79.57 | -43.243 | -40.965 | -37.814 | -55.047 | -51.091 | -50.92 | -40.665 | -35.826 | -36.662 | -36.552 | -34.843 | -53.721 | -34.105 | -21.101 | -20.141 | -98.006 | -68.112 | -87.762 | -1.251 | -0.484 | -0.29 | -0.257 | -0.257 |
| Income Before Tax Ratio
| -1.919 | -3.307 | -2.51 | -5.233 | -12.486 | -43.333 | -116.672 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0 | 0 | 0.171 | 0 | 0 | 0 | 0 | 8.405 | 8.562 | 0 | 2.759 | 0 | 0 | 0 | 0 | 0 | 0 | 0.182 | 0 | 0 | 0 | 0 | 0.011 | 0 | 0 | 0 | 0 |
| Net Income
| -75.81 | -94.316 | -74.451 | -85.577 | -91.446 | -82.852 | -79.57 | -43.243 | -40.965 | -37.814 | -63.452 | -59.653 | -50.92 | -43.424 | -35.826 | -36.662 | -36.552 | -34.843 | -53.721 | -34.105 | -21.101 | -20.141 | -98.006 | -68.112 | -87.762 | -1.251 | -0.484 | -0.29 | -0.257 | -0.257 |
| Net Income Ratio
| -1.919 | -3.307 | -2.51 | -5.233 | -12.486 | -43.333 | -116.672 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.046 | -1.31 | -1.05 | -1.32 | -1.56 | -1.42 | -1.39 | -0.76 | -0.84 | -0.89 | -1.54 | -1.54 | -1.33 | -1.14 | -0.95 | -0.98 | -1 | -0.96 | -1.58 | -1.02 | -0.64 | -0.62 | -3.02 | -2.98 | -10.23 | -0.15 | -0.056 | -0.034 | -0.048 | -0.048 |
| EPS Diluted
| -1.046 | -1.31 | -1.05 | -1.32 | -1.56 | -1.42 | -1.39 | -0.76 | -0.84 | -0.89 | -1.54 | -1.54 | -1.33 | -1.14 | -0.95 | -0.98 | -1 | -0.96 | -1.58 | -1.02 | -0.64 | -0.62 | -3.02 | -2.98 | -10.23 | -0.15 | -0.056 | -0.034 | -0.048 | -0.048 |
| EBITDA
| -58.12 | -78.863 | -55.665 | -66.902 | -73.485 | -65.47 | -66.356 | -33.015 | -31.227 | -28.451 | -45.277 | -41.639 | -45.104 | -37.778 | -32.916 | -35.047 | -35.165 | -33.446 | -52.333 | -32.731 | -19.762 | -19.351 | -96.961 | -66.122 | -85.341 | 0 | -0.479 | -0.286 | -0.004 | -0.004 |
| EBITDA Ratio
| -1.471 | -2.765 | -1.877 | -4.091 | -10.033 | -34.242 | -97.296 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |